BiondVax Pharmaceuticals

YTD

ALL

Why Robinhood?

You can watch BVXV and buy or sell other stocks, options, and ETFs commission-free!

About BVXV

Scinai Immunotherapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. It focuses on the flu vaccine candidate that was designed to provide multi-strain and multi-season protection against seasonal and pandemic influenza.

CEO

Amir Reichman, MBA

CEOAmir Reichman, MBA

Employees

—

Employees—

Headquarters

Jerusalem, Jerusalem

HeadquartersJerusalem, Jerusalem

Founded

2003

Founded2003

Employees

—

Employees—

BVXV Key Statistics

Market cap

2.09M

Market cap2.09M

Price-Earnings ratio

-0.08

Price-Earnings ratio-0.08

Dividend yield

—

Dividend yield—

Average volume

17.48K

Average volume17.48K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$2.27

52 Week high$2.27

52 Week low

$0.4311

52 Week low$0.4311